Cargando…
Differences in virus receptor for type I and type II feline infectious peritonitis virus
Feline infectious peritonitis viruses (FIPVs) are classified into type I and type II serogroups. Here, we report that feline aminopeptidase N (APN), a cell-surface metalloprotease on the intestinal, lung and kidney epithelial cells, is a receptor for type II FIPV but not for type I FIPV. A monoclona...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087195/ https://www.ncbi.nlm.nih.gov/pubmed/9645192 http://dx.doi.org/10.1007/s007050050336 |
_version_ | 1783509288133591040 |
---|---|
author | Hohdatsu, T. Izumiya, Y. Yokoyama, Y. Kida, K. Koyama, H. |
author_facet | Hohdatsu, T. Izumiya, Y. Yokoyama, Y. Kida, K. Koyama, H. |
author_sort | Hohdatsu, T. |
collection | PubMed |
description | Feline infectious peritonitis viruses (FIPVs) are classified into type I and type II serogroups. Here, we report that feline aminopeptidase N (APN), a cell-surface metalloprotease on the intestinal, lung and kidney epithelial cells, is a receptor for type II FIPV but not for type I FIPV. A monoclonal antibody (MAb) R-G-4, which blocks infection of Felis catus whole fetus (fcwf-4) cells by type II FIPV, was obtained by immunizing mice with fcwf-4 cells which are highly susceptible to FIPV. This MAb also blocked infection of fcwf-4 cells by type II feline enteric coronavirus (FECV), canine coronavirus (CCV), and transmissible gastroenteritis virus (TGEV). On the other hand, it did not block infection by type I FIPVs. MAb R-G-4 recognized a polypeptide of relative molecular mass 120–130 kDa in feline intestinal brush-border membrane (BBM) proteins. The polypeptide possessed aminopeptidase activity, and the first 15 N-terminal amino acid sequence was identical to that of the feline APN. Feline intestinal BBM proteins and the polypeptide reacted with MAb R-G-4 (feline APN) inhibited the infectivity of type II FIPV, type II FECV, CCV and TGEV to fcwf-4 cells, but did not inhibit the infectivity of type I FIPVs. |
format | Online Article Text |
id | pubmed-7087195 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-70871952020-03-23 Differences in virus receptor for type I and type II feline infectious peritonitis virus Hohdatsu, T. Izumiya, Y. Yokoyama, Y. Kida, K. Koyama, H. Arch Virol Article Feline infectious peritonitis viruses (FIPVs) are classified into type I and type II serogroups. Here, we report that feline aminopeptidase N (APN), a cell-surface metalloprotease on the intestinal, lung and kidney epithelial cells, is a receptor for type II FIPV but not for type I FIPV. A monoclonal antibody (MAb) R-G-4, which blocks infection of Felis catus whole fetus (fcwf-4) cells by type II FIPV, was obtained by immunizing mice with fcwf-4 cells which are highly susceptible to FIPV. This MAb also blocked infection of fcwf-4 cells by type II feline enteric coronavirus (FECV), canine coronavirus (CCV), and transmissible gastroenteritis virus (TGEV). On the other hand, it did not block infection by type I FIPVs. MAb R-G-4 recognized a polypeptide of relative molecular mass 120–130 kDa in feline intestinal brush-border membrane (BBM) proteins. The polypeptide possessed aminopeptidase activity, and the first 15 N-terminal amino acid sequence was identical to that of the feline APN. Feline intestinal BBM proteins and the polypeptide reacted with MAb R-G-4 (feline APN) inhibited the infectivity of type II FIPV, type II FECV, CCV and TGEV to fcwf-4 cells, but did not inhibit the infectivity of type I FIPVs. Springer-Verlag 2014-04-07 1998 /pmc/articles/PMC7087195/ /pubmed/9645192 http://dx.doi.org/10.1007/s007050050336 Text en © Springer-Verlag 1998 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Hohdatsu, T. Izumiya, Y. Yokoyama, Y. Kida, K. Koyama, H. Differences in virus receptor for type I and type II feline infectious peritonitis virus |
title | Differences in virus receptor for type I and type II feline infectious peritonitis virus |
title_full | Differences in virus receptor for type I and type II feline infectious peritonitis virus |
title_fullStr | Differences in virus receptor for type I and type II feline infectious peritonitis virus |
title_full_unstemmed | Differences in virus receptor for type I and type II feline infectious peritonitis virus |
title_short | Differences in virus receptor for type I and type II feline infectious peritonitis virus |
title_sort | differences in virus receptor for type i and type ii feline infectious peritonitis virus |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087195/ https://www.ncbi.nlm.nih.gov/pubmed/9645192 http://dx.doi.org/10.1007/s007050050336 |
work_keys_str_mv | AT hohdatsut differencesinvirusreceptorfortypeiandtypeiifelineinfectiousperitonitisvirus AT izumiyay differencesinvirusreceptorfortypeiandtypeiifelineinfectiousperitonitisvirus AT yokoyamay differencesinvirusreceptorfortypeiandtypeiifelineinfectiousperitonitisvirus AT kidak differencesinvirusreceptorfortypeiandtypeiifelineinfectiousperitonitisvirus AT koyamah differencesinvirusreceptorfortypeiandtypeiifelineinfectiousperitonitisvirus |